Is HCA or CHE a better buy right now?

Based on our latest analysis, CHE is currently the stronger investment candidate based on our comprehensive scoring model.

Does HCA or CHE have better growth?

Our analysis compares revenue and earnings growth. Check the 'Growth' section above to see which company is expanding faster. Typically, the stock with higher revenue growth rates is considered the better growth stock.

Which stock is cheaper: HCA or CHE?

We compare P/E ratios and other valuation metrics in the 'Valuation' section. The stock with the lower P/E ratio is generally considered 'cheaper' relative to its earnings, though growth prospects must also be considered.

Which is the better buy right now, HCA or CHE?

As of Nov 06, 2026, CHE scores higher in our model: HCA has an AI score of 36.3 versus 50.1 for CHE. HCA is currently in a Markup technical phase and CHE is in a Neutral phase. Consider both scores and phases alongside your own risk tolerance.

What technical phase are HCA and CHE in?

HCA is in a Markup phase (Hold / add on dips) with an RSI of 65.3. CHE is in a Neutral phase (Hold) with an RSI of 62.2.

HCA vs CHE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

HCA

36.3

AI Score

CHE Wins

CHE

50.1

AI Score

Investment Advisor Scores

HCA

36score

Recommendation

SELL

View Full Analysis

CHE

50score

Recommendation

HOLD

View Full Analysis

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric	HCA	CHE	Winner
Revenue	59.19B	1.79B	HCA
Net Income	4.90B	211.68M	HCA
Net Margin	8.3%	11.8%	CHE
ROE	-60.6%	17.1%	CHE
ROA	7.7%	12.0%	CHE
Total Assets	63.45B	1.77B	HCA
Cash	908.00M	238.45M	HCA
Current Ratio	0.82	1.85	CHE
Free Cash Flow	5.10B	215.81M	HCA

Relative Price Performance (Last 90 Days)

HCA 1M: +9.8% · 3M: +22.9% CHE 1M: +10.0% · 3M: +2.5%

Current Technical Phase

HCA

Markup

Hold / add on dips

Price above SMA50, rising 50-day trend (5.8% over 20 days), RSI 65

RSI (14): 65.3 · Price: $506.04

CHE

Neutral

Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.2 · Price: $550.62

Fundamentals Snapshot

Metric	HCA	CHE
Market Cap	—	—
Forward P/E	16.2	19.8
Trailing P/E	16.7	26.1
Revenue (TTM)	—	—
Revenue Growth	0.0%	0.1%
Gross Margin	0.4%	0.3%
Operating Margin	0.1%	0.2%
EPS	30.12	20.88
Dividend Yield	0.01%	0.00%

Frequently Asked Questions

Based on our detailed analysis, CHE is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.

Related Analysis

HCA

CHE

Data derived from SEC EDGAR filings and Tradestie proprietary analysis. Last updated: Nov 06, 2026 21:57 UTC. Refresh Data

Tradestie